JP2010534699A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010534699A5 JP2010534699A5 JP2010518590A JP2010518590A JP2010534699A5 JP 2010534699 A5 JP2010534699 A5 JP 2010534699A5 JP 2010518590 A JP2010518590 A JP 2010518590A JP 2010518590 A JP2010518590 A JP 2010518590A JP 2010534699 A5 JP2010534699 A5 JP 2010534699A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- alkyl
- formula
- treatment
- pediatric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000012191 childhood neoplasm Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000003911 head and neck carcinoma Diseases 0.000 claims 1
- 201000000459 head and neck squamous cell carcinoma Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000029340 primitive neuroectodermal tumor Diseases 0.000 claims 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims 1
- 0 *CCON=Cc1c(CN(C2=CC(C3O)=C4COC3=O)C4=O)c2nc2c1cccc2 Chemical compound *CCON=Cc1c(CN(C2=CC(C3O)=C4COC3=O)C4=O)c2nc2c1cccc2 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07113603 | 2007-08-01 | ||
| EP07113603.0 | 2007-08-01 | ||
| PCT/EP2008/058601 WO2009015981A2 (en) | 2007-08-01 | 2008-07-03 | Treatment of pediatric tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014042649A Division JP2014111653A (ja) | 2007-08-01 | 2014-03-05 | 小児腫瘍の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010534699A JP2010534699A (ja) | 2010-11-11 |
| JP2010534699A5 true JP2010534699A5 (enExample) | 2011-08-04 |
| JP5765937B2 JP5765937B2 (ja) | 2015-08-19 |
Family
ID=38799381
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518590A Expired - Fee Related JP5765937B2 (ja) | 2007-08-01 | 2008-07-03 | 小児腫瘍の治療 |
| JP2014042649A Ceased JP2014111653A (ja) | 2007-08-01 | 2014-03-05 | 小児腫瘍の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014042649A Ceased JP2014111653A (ja) | 2007-08-01 | 2014-03-05 | 小児腫瘍の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8829021B2 (enExample) |
| EP (1) | EP2182951A2 (enExample) |
| JP (2) | JP5765937B2 (enExample) |
| KR (1) | KR20100051837A (enExample) |
| CN (1) | CN101784277A (enExample) |
| BR (1) | BRPI0815051A2 (enExample) |
| CA (1) | CA2694389C (enExample) |
| EA (1) | EA015933B1 (enExample) |
| MX (1) | MX2010001084A (enExample) |
| SG (1) | SG183010A1 (enExample) |
| WO (1) | WO2009015981A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2889711A1 (en) | 2012-10-29 | 2014-05-08 | Arizona Board Of Regents On Behalf Of University Of Arizona | Predictive markers for polyamine inhibitor cancer therapies |
| JP2017519770A (ja) | 2014-06-18 | 2017-07-20 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナ | Ｏｄｃ１遺伝子型に基づく癌腫の診断および処置 |
| EP3256117A4 (en) * | 2015-02-12 | 2018-10-10 | The Arizona Board of Regents on behalf of The University of Arizona | Methods for treating neuroblastoma |
| MA43114A (fr) | 2015-10-30 | 2018-09-05 | Cancer Prevention Pharmaceuticals Inc | Formulation combinée à dose fixe d'éflornithine et sulindac |
| CN114096240A (zh) | 2019-05-17 | 2022-02-25 | 癌症预防制药股份有限公司 | 用于治疗家族性腺瘤性息肉病的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1044977T1 (en) * | 1999-03-09 | 2002-08-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Camptothecin derivatives having antitumor activity |
| HRP20120359T1 (hr) * | 2005-12-21 | 2012-06-30 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Liječenje tumora rezistentnih na lijekove |
| US8853233B2 (en) * | 2007-02-13 | 2014-10-07 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives |
-
2008
- 2008-07-03 CA CA2694389A patent/CA2694389C/en not_active Expired - Fee Related
- 2008-07-03 EA EA201070193A patent/EA015933B1/ru not_active IP Right Cessation
- 2008-07-03 EP EP08774713A patent/EP2182951A2/en not_active Withdrawn
- 2008-07-03 WO PCT/EP2008/058601 patent/WO2009015981A2/en not_active Ceased
- 2008-07-03 KR KR1020107004521A patent/KR20100051837A/ko not_active Ceased
- 2008-07-03 SG SG2012050597A patent/SG183010A1/en unknown
- 2008-07-03 BR BRPI0815051-6A2A patent/BRPI0815051A2/pt not_active IP Right Cessation
- 2008-07-03 US US12/669,134 patent/US8829021B2/en not_active Expired - Fee Related
- 2008-07-03 CN CN200880101385A patent/CN101784277A/zh active Pending
- 2008-07-03 JP JP2010518590A patent/JP5765937B2/ja not_active Expired - Fee Related
- 2008-07-03 MX MX2010001084A patent/MX2010001084A/es active IP Right Grant
-
2014
- 2014-03-05 JP JP2014042649A patent/JP2014111653A/ja not_active Ceased